Brind.
  1. Soligenix, Inc. collaborated with John A. Burns School of Medicine on vaccine development relevant for virus-endemic countries in Africa.

Vaccine trials are being conducted in Africa, alongside WHO estimates of the disease burden.

4 reports, 3 independent Updated Aug 7
Gone quiet
Reports
4
Developments
3
Repetition
75%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Well supportedReported by 3 independent outlets

Vaccine trials are being conducted in Africa, alongside WHO estimates of the disease burden.

Who's involved

What this event is mainly about
AfricaWorld Health Organization

How it developed

Newest first. Tap a step to see who reported it.
  1. CEPI provided support for the Tumaini trial, where a Merck vaccine is being administered in the Democratic Republic of the Congo.Sub-event
  2. Texas Tech University led the development of the SchistoShield vaccine for schistosomiasis, conducting trials in African locations.Sub-event
  3. Vaccine trials are underway in Africa, coinciding with WHO estimates of disease burden.1 source

Keep exploring

Part of

Soligenix, Inc. collaborated with John A. Burns School of Medicine on vaccine development relevant for virus-endemic countries in Africa. All 1 developments

The entities involved

Related events

Coverage

Newest first; wire copies grouped
1 more outlet ran the same wire story